The impact of pharmacist-led antimicrobial stewardship program on antibiotic use in a county-level tertiary general hospital in China: A retrospective study using difference-in-differences design

被引:11
作者
Wang, Ying [1 ,2 ]
Zhou, Chongchong [3 ]
Liu, Chengying [4 ]
Liu, Shuanghai [5 ]
Liu, Xiaoliang [6 ]
Li, Xin [2 ,3 ,7 ]
机构
[1] Soochow Univ, Affiliated Hosp 1, Dept Infect Management, Suzhou, Peoples R China
[2] Nanjing Med Univ, Sch Hlth Policy & Management, Nanjing, Peoples R China
[3] Nanjing Med Univ, Sch Pharm, Dept Clin Pharm, Nanjing, Peoples R China
[4] Nantong Univ, Dept Resp Med, Affiliated Jiangyin Hosp, Nantong, Jiangyin, Peoples R China
[5] Nantong Univ, Dept Hepatobiliary Surg, Affiliated Jiangyin Hosp, Nantong, Jiangyin, Peoples R China
[6] Nantong Univ, Dept Infect Management, Affiliated Jiangyin Hosp, Nantong, Jiangyin, Peoples R China
[7] Nanjing Med Univ, Ctr Global Hlth, Sch Publ Hlth, Nanjing, Peoples R China
基金
中国国家自然科学基金;
关键词
antibiotics use; antimicrobial stewardship; pharmacist; difference-in-differences; county-level general hospital; INFECTIOUS-DISEASES SOCIETY; HEALTH-CARE EPIDEMIOLOGY; INSTITUTIONAL PROGRAM; AMERICA GUIDELINES; THERAPY;
D O I
10.3389/fpubh.2022.1012690
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundInappropriate use of antibiotics has become a major driver for the spread of antimicrobial resistance globally, particularly common in China. Antimicrobial stewardship programs are effective in optimizing antimicrobial use and decreasing the emergence of multi-drug-resistant organisms, and the pharmacist has performed a leading role in this program. ObjectiveTo evaluate the impact of antimicrobial stewardship programs driven by pharmacists on antibiotic consumption and costs and the appropriateness of antibiotic use. MethodsA single-center retrospective quasi-experimental design was conducted in two independent hepatobiliary surgery wards and two independent respiratory wards in a county-level tertiary general hospital in Jiangsu, China. Each intervention group was served with antimicrobial stewardship programs with prescriptions audit and feedback, antibiotics restriction, education, and training. The propensity score matching method was employed to balance confounding variables between the intervention group and control group, and a difference-in-differences analysis was used to evaluate the impact of antimicrobial stewardship programs. The primary outcome was measured by scores of rationality evaluation of antibiotics. ResultsThe DID results demonstrated that the implementation of the antimicrobial stewardship programs was associated with a reduction in the average length of hospital stay (coefficient = -3.234, p = 0.006), DDDs per patient (coefficient = -2.352, p = 0.047), and hospitalization costs (coefficient = -7745.818, p = 0.005) in the hepatobiliary surgery ward, while it was associated with a decrease in DDDs per patient (coefficient = -3.948, p = 0.029), defined daily doses per patient day (coefficient = -0.215, p = 0.048), and antibiotic costs (coefficient = -935.087, p = 0.014) in the respiratory ward. The program was also associated with a decrease in rationality evaluation scores (p < 0.001) in two wards. ConclusionThe result reveals that the implementation of the antimicrobial stewardship programs is effective in reducing the length of hospital stay, decreasing antibiotics consumption and costs, and improving the appropriateness of antimicrobial use such as decreasing irrational use of cephalosporins, reducing combinations, and improving timely conversion. However, great attention ought to be paid to the improper use of broad-spectrum antibiotics. The government is responsible for providing sustainable formal education for pharmacists, and more funding and staff support to promote antimicrobial stewardship programs.
引用
收藏
页数:13
相关论文
共 29 条
[1]  
[Anonymous], 2010, Am J Health Syst Pharm, V67, P575, DOI 10.2146/sp100001
[2]   Impact of an Antimicrobial Stewardship Intervention on Shortening the Duration of Therapy for Community-Acquired Pneumonia [J].
Avdic, Edina ;
Cushinotto, Lisa A. ;
Hughes, Andrew H. ;
Hansen, Amanda R. ;
Efird, Leigh E. ;
Bartlett, John G. ;
Cosgrove, Sara E. .
CLINICAL INFECTIOUS DISEASES, 2012, 54 (11) :1581-1587
[3]   A Call to Arms: The Imperative for Antimicrobial Stewardship [J].
Bartlett, John G. .
CLINICAL INFECTIOUS DISEASES, 2011, 53 :S4-S7
[4]   Evaluating the impact of a pharmacist's absence from an antimicrobial stewardship team [J].
Cappelletty, Diane ;
Jacobs, David .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (12) :1065-1069
[5]  
Committee of experts on rational drug use National health and family planning commission of the P. R. China: China Antimicrobial Resistance Surveillance System, 2016, CHINA LICENSED PHARM, V13, P3, DOI DOI 10.3969/J.ISSN.1672-5433.2016.03.001
[6]  
Core Elements of Hospital Antibiotics Stewardship Programs, 2018, CORE ELEMENTS HOSP A
[7]   Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship [J].
Dellit, Timothy H. ;
Owens, Robert C. ;
McGowan, John E., Jr. ;
Gerding, Dale N. ;
Weinstein, Robert A. ;
Burke, John P. ;
Huskins, W. Charles ;
Paterson, David L. ;
Fishman, Neil O. ;
Carpenter, Christopher F. ;
Brennan, P. J. ;
Billeter, Marianne ;
Hooton, Thomas M. .
CLINICAL INFECTIOUS DISEASES, 2007, 44 (02) :159-177
[8]   Antibiotic use in rural China: a cross-sectional survey of knowledge, attitudes and self-reported practices among caregivers in Shandong province [J].
Ding, Lilu ;
Sun, Qiang ;
Sun, Weishuai ;
Du, Yihui ;
Li, Yue ;
Bian, Xuefeng ;
He, Guiqin ;
Bai, Huidong ;
Dyar, Oliver J. .
BMC INFECTIOUS DISEASES, 2015, 15
[9]   Impact of a Multifaceted Pharmacist-Led Intervention on Antimicrobial Stewardship in a Gastroenterology Ward: A Segmented Regression Analysis [J].
Du Yaling ;
Li Jing ;
Wang Xinchun ;
Peng Xi ;
Wang Xiaoyi ;
He Wenying ;
Li Yan ;
Wang Xuemei ;
Yang Qiuxia ;
Zhang Xinping .
FRONTIERS IN PHARMACOLOGY, 2020, 11
[10]  
Fang Y., 2016, PHARM PRACTICE DEVEL, P57